NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 351 filers reported holding NOVAVAX INC in Q4 2020. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4,796,798 | +670.2% | 378,894 | +190.8% | 0.01% | – |
Q1 2024 | $622,834 | -74.0% | 130,300 | -60.6% | 0.00% | -100.0% |
Q3 2023 | $2,391,372 | +146161.3% | 330,300 | +33.1% | 0.00% | +50.0% |
Q1 2023 | $1,635 | -55.1% | 248,100 | -30.0% | 0.00% | -60.0% |
Q4 2022 | $3,645 | -100.0% | 354,600 | +35.8% | 0.01% | -77.3% |
Q2 2022 | $13,538,000 | -39.1% | 261,102 | -12.1% | 0.02% | -24.1% |
Q1 2022 | $22,216,000 | -63.9% | 297,203 | -25.2% | 0.03% | -60.3% |
Q4 2021 | $61,534,000 | -29.7% | 397,431 | -7.6% | 0.07% | -26.3% |
Q3 2021 | $87,553,000 | +1.7% | 430,171 | +4.4% | 0.10% | -25.6% |
Q2 2021 | $86,124,000 | +55.8% | 412,196 | +29.3% | 0.13% | +60.2% |
Q1 2021 | $55,272,000 | +43.8% | 318,906 | -1.3% | 0.08% | +38.3% |
Q4 2020 | $38,449,000 | +28.8% | 323,214 | +16.8% | 0.06% | -17.8% |
Q3 2020 | $29,860,000 | +82.3% | 276,612 | +41.2% | 0.07% | +65.9% |
Q2 2020 | $16,377,000 | +499.7% | 195,873 | +2.6% | 0.04% | +388.9% |
Q1 2020 | $2,731,000 | – | 190,958 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 3,002,087 | $544,308,000 | 8.21% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 323,517 | $58,657,000 | 7.86% |
Samsara BioCapital, LLC | 198,600 | $36,008,000 | 6.64% |
Foresite Capital Management I, LLC | 66,810 | $12,113,000 | 6.11% |
Foresite Capital Management II, LLC | 67,373 | $12,215,000 | 2.81% |
SECTORAL ASSET MANAGEMENT INC | 191,200 | $34,666,000 | 2.63% |
Rock Springs Capital Management LP | 461,000 | $83,584,000 | 1.82% |
TSP Capital Management Group, LLC | 23,525 | $4,265,000 | 1.50% |
Ikarian Capital, LLC | 195,700 | $35,483,000 | 1.19% |
SevenOneSeven Capital Management | 1,744 | $316,000 | 1.16% |